尼古拉斯•Donoghoe医学博士

As Senior Vice President, R&D Chief Operating Officer, Dr. Nicholas Donoghoe leads the operational and strategic advancement of AbbVie’s pipeline. He oversees Clinical Development Operations (CDO), Transformation/Innovation and Health Economics and Outcomes Research (HEOR) to deliver remarkable therapies to our patients globally. Additionally, Dr. Donoghoe leads Search and Evaluation, Business Development and Acquisitions, Global Alliances and Corporate Strategy in the establishment of strategy and partnerships across the development continuum that will benefit patients and fuel scientific progress.
\r\n
\r\nDr. Donoghoe previously held leadership roles across R&D and Commercial, in both AbbVie’s Therapeutic and Aesthetic businesses. He was a partner at McKinsey & Co and has an M.D. from Johns Hopkins School of Medicine.

\r\n"}}" id="text-b27f29fc1c" class="cmp-text">

高级副总裁、首席运营官研发尼古拉斯Donoghoe博士领导的运营和战略发展AbbVie的管道。他负责临床开发操作(CDO)、转换/创新和狗万正网地址卫生经济学和成果研究(HEOR)全球提供显著的治疗病人。此外,博士Donoghoe搜索和评估,业务开发和收购,建立全球联盟和企业战略发展战略和伙伴关系的连续性,有利于患者和燃料科学进步。狗万正网地址

博士Donoghoe之前在研发和商业领导角色,在AbbVie的治疗和美学的业务。他是麦肯锡的合伙人,约翰霍普金斯大学医学院的医学博士。